Emerging Strategies for the Management of Atherogenic Dyslipidaemia

被引:6
作者
Agarwala, Anandita [1 ]
Shapiro, Michael D. [2 ]
机构
[1] Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA
[2] Wake Forest Univ, Baptist Med Ctr, Sect Cardiovasc Med, Ctr Prevent Cardiovasc Dis, Winston Salem, NC 27157 USA
关键词
CARDIOVASCULAR RISK; LIPOPROTEIN(A); ANGPTL3; ANTIBODY; DISEASE;
D O I
10.15420/ecr.2019.16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:38 / 40
页数:3
相关论文
共 31 条
  • [1] The Use of Risk-Enhancing Factors to Personalize ASCVD Risk Assessment: Evidence and Recommendations from the 2018 AHA/ACC Multi-Society Cholesterol Guidelines
    Agarwala, Anandita
    Liu, Jing
    Ballantyne, Christie M.
    Virani, Salim S.
    [J]. CURRENT CARDIOVASCULAR RISK REPORTS, 2019, 13 (07)
  • [2] Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
    Ahmad, Zahid
    Banerjee, Poulabi
    Hamon, Sara
    Chan, Kuo-Chen
    Bouzelmat, Aurelie
    Sasiela, William J.
    Pordy, Robert
    Mellis, Scott
    Dansky, Hayes
    Gipe, Daniel A.
    Dunbar, Richard L.
    [J]. CIRCULATION, 2019, 140 (06) : 470 - 486
  • [3] N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
    Alexander, Veronica J.
    Xia, Shuting
    Hurh, Eunju
    Hughes, Steven G.
    O'Dea, Louis
    Geary, Richard S.
    Witztum, Joseph L.
    Tsimikas, Sotirios
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (33) : 2785 - 2796
  • [4] [Anonymous], 2019, J AM HEART ASSOC
  • [5] Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
    Ballantyne, Christie M.
    Laufs, Ulrich
    Ray, Kausik K.
    Leiter, Lawrence A.
    Bays, Harold E.
    Goldberg, Anne C.
    Stroes, Erik S. G.
    MacDougall, Diane
    Zhao, Xin
    Catapano, Alberico L.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (06) : 593 - 603
  • [6] Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
    Ballantyne, Christie M.
    Banach, Maciej
    Mancini, G. B. John
    Lepor, Norman E.
    Hanselman, Jeffrey C.
    Zhao, Xin
    Leiter, Lawrence A.
    [J]. ATHEROSCLEROSIS, 2018, 277 : 195 - 203
  • [7] Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies A Mendelian Randomization Analysis
    Burgess, Stephen
    Ference, Brian A.
    Staley, James R.
    Freitag, Daniel F.
    Mason, Amy M.
    Nielsen, Sune F.
    Willeit, Peter
    Young, Robin
    Surendran, Praveen
    Karthikeyan, Savita
    Bolton, Thomas R.
    Peters, James E.
    Kamstrup, Pia R.
    Tybjaerg-Hansen, Anne
    Benn, Marianne
    Langsted, Anne
    Schnohr, Peter
    Vedel-Krogh, Signe
    Kobylecki, Camilla J.
    Ford, Ian
    Packard, Chris
    Trompet, Stella
    Jukema, J. Wouter
    Sattar, Naveed
    Di Angelantonio, Emanuele
    Saleheen, Danish
    Howson, Joanna M. M.
    Nordestgaard, Borge G.
    Butterworth, Adam S.
    Danesh, John
    [J]. JAMA CARDIOLOGY, 2018, 3 (07) : 619 - 627
  • [8] Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
    Conroy, RM
    Pyörälä, K
    Fitzgerald, AP
    Sans, S
    Menotti, A
    De Backer, G
    De Bacquer, D
    Ducimetière, P
    Jousilahti, P
    Keil, U
    Njolstad, I
    Oganov, RG
    Thomsen, T
    Tunstall-Pedoe, H
    Tverdal, A
    Wedel, H
    Whincup, P
    Wilhelmsen, L
    Graham, IM
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (11) : 987 - 1003
  • [9] Lipoprotein(a) and Cardiovascular Risk Prediction Among Women
    Cook, Nancy R.
    Mora, Samia
    Ridker, Paul M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (03) : 287 - 296
  • [10] Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
    Dewey, F. E.
    Gusarova, V.
    Dunbar, R. L.
    O'Dushlaine, C.
    Schurmann, C.
    Gottesman, O.
    McCarthy, S.
    Van Hout, C. V.
    Bruse, S.
    Dansky, H. M.
    Leader, J. B.
    Murray, M. F.
    Ritchie, M. D.
    Kirchner, H. L.
    Habegger, L.
    Lopez, A.
    Penn, J.
    Zhao, A.
    Shao, W.
    Stahl, N.
    Murphy, A. J.
    Hamon, S.
    Bouzelmat, A.
    Zhang, R.
    Shumel, B.
    Pordy, R.
    Gipe, D.
    Herman, G. A.
    Sheu, W. H. H.
    Lee, I-T.
    Liang, K. -W.
    Guo, X.
    Rotter, J. I.
    Chen, Y. -D. I.
    Kraus, W. E.
    Shah, S. H.
    Damrauer, S.
    Small, A.
    Rader, D. J.
    Wulff, A. B.
    Nordestgaard, B. G.
    Tybjaerg-Hansen, A.
    van den Hoek, A. M.
    Princen, H. M. G.
    Ledbetter, D. H.
    Carey, D. J.
    Overton, J. D.
    Reid, J. G.
    Sasiela, W. J.
    Banerjee, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (03) : 211 - 221